Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo.
about
Improvement of human keratinocyte migration by a redox active bioelectric dressingFERM domain-containing unconventional myosin VIIA interacts with integrin β5 subunit and regulates αvβ5-mediated cell adhesion and migrationCAS/Crk coupling serves as a "molecular switch" for induction of cell migration.Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growthConcerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motilityTargeting migration inducting gene-7 inhibits carcinoma cell invasion, early primary tumor growth, and stimulates monocyte oncolytic activityOverexpression of wild-type PKD2 leads to increased proliferation and invasion of BON endocrine cellsSrc-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling.P21-activated kinase 4 interacts with integrin alpha v beta 5 and regulates alpha v beta 5-mediated cell migrationOverexpression of carcinoma and embryonic cytotrophoblast cell-specific Mig-7 induces invasion and vessel-like structure formationA selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasionαV integrins in angiogenesis and cancerDisintegrins from snake venoms and their applications in cancer research and therapy.Understanding cachexia as a cancer metabolism syndromeMechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cellsp21-activated kinase 4 phosphorylation of integrin beta5 Ser-759 and Ser-762 regulates cell migrationIntegrins in cancer: biological implications and therapeutic opportunitiesMyosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner.Cell and molecular mechanisms of keratinocyte function stimulated by insulin during wound healing.Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation.The contradictions of the insulin-like growth factor 1 receptor.EGFR-mediated carcinoma cell metastasis mediated by integrin αvβ5 depends on activation of c-Src and cleavage of MUC1.Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulationEndometrial anomalies in women with endometriosis.Inhibition of experimental metastasis by targeting the HUIV26 cryptic epitope in collagen.Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis.Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis.Targeting integrins for the control of tumour angiogenesis.Effect of insulin-like growth factor blockade on hyperoxia-induced lung injury.Macrophage and retinal pigment epithelium phagocytosis: apoptotic cells and photoreceptors compete for alphavbeta3 and alphavbeta5 integrins, and protein kinase C regulates alphavbeta5 binding and cytoskeletal linkage.Regulation of protumorigenic pathways by insulin like growth factor binding protein2 and its association along with β-catenin in breast cancer lymph node metastasis.Establishment and maintenance of cell polarity during leukocyte chemotaxisIntegrins in angiogenesis and lymphangiogenesisSyndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.Integrin and growth factor receptor alliance in angiogenesis.Roles of integrins in tumor angiogenesis and lymphangiogenesis.Transcriptional landscapes of emerging autoimmunity: transient aberrations in the targeted tissue's extracellular milieu precede immune responses in Sjögren's syndrome.Cross-talk between the insulin-like growth factor (IGF) axis and membrane integrins to regulate cell physiology.mTOR signaling in cancer cell motility and tumor metastasis.Angiogenesis in cancer: Anti-VEGF escape mechanisms
P2860
Q21090652-3CB0F90C-1922-4FAB-A052-7143A06C46D3Q24300327-FC0EA814-779D-4D98-8F50-A7B8778C4E57Q24311510-941A30F3-3F58-4408-8F11-BC3E3F29EAD0Q24521364-BEC2C4C9-C0F0-4A75-8E2E-F3F175ACD81DQ24554511-BF6C23B7-AE46-4B49-BBE4-069ED611BA12Q24650655-E5D44790-D74C-438A-BEB7-1C3C20B627D5Q24653394-3CA57085-3F39-4622-A4C5-A53F5FE47CD4Q24673519-1A629D80-4F13-4EBB-8A7A-563402D53496Q24673583-5973F33A-960D-4D30-9C15-18F130ABAF77Q24681648-B020696F-7455-473F-A355-5C1D47BFF8DAQ24812140-5E23639B-6C25-4049-9C39-64B5C4588495Q26851768-AFAB003F-F1C6-4E04-A5EB-A48D3B483108Q27000037-654AFECD-F353-45F8-8824-F8313CAE96DDQ28069390-5F540667-3D27-478C-A179-4A0216388A3EQ28213888-6811E59D-B6A6-401B-9D85-7EDCDF3E0C6EQ28283681-4D44ABA2-B648-41B3-A370-D2BBC0F68EB4Q29614536-7346306A-A783-4EF8-9EEB-67E69914BD81Q30304130-D12E5A3B-8647-44D8-BF79-D369AD5092A2Q33398848-0C9189DC-67C6-44F7-BD98-7DA7DD95E7FAQ33604753-23C13001-DE34-4FAE-BACB-92244AA83A8AQ34103628-5AECBA9B-0E27-4B82-89EA-812DF5BCAA0EQ34269196-3A2C8722-EFA5-4095-82E0-93A43BE3BBEFQ34387886-EEA0F291-10A7-4F24-9582-9850B20CA108Q34397179-B1C7110C-BF1E-4998-949F-CB9334E44AB9Q35088252-3DDC568A-3681-4748-B040-398D13EA0BCAQ35178613-300D5DD8-320F-4EB7-B883-4F452EBF4B07Q35789179-A553C85C-AA1D-48B9-AE57-5E3986786272Q36322066-95A0DC72-5825-49F1-B225-67076D9FABA4Q36370176-35502FBE-E406-4DB1-BE6C-F27105A2057EQ36375325-4BEED643-D375-4A16-A965-DD50C61ACBA8Q36972353-423F8B6C-09AF-471D-9DC6-41B850B88F27Q37079866-A2514EBF-0B93-4E10-933C-145FC9DA2952Q37170752-B60306D6-C2DB-4B03-B4F6-82C5554213F7Q37234281-894D50D1-B9CC-4EB0-9133-B6BD0E6AA24DQ37339044-9E6B0DEE-F383-4AD7-90B5-4B3BE2E7DC6DQ37354204-5FD4C3FE-BD0B-4DEF-9D00-4C2307541FA1Q37689748-DD8CAA23-3AEF-48E0-994A-0EDD5F6AE682Q37740002-C54B7105-6249-4EC6-8A22-728D1F343CA5Q37763231-FBFF4D51-BB31-44BA-A7A6-24F5DF76A6D5Q38389975-1E8CB0BB-279F-4B4D-B2CA-3B34BDF40E43
P2860
Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Insulin-like growth factor rec ...... or cell dissemination in vivo.
@en
Insulin-like growth factor rec ...... or cell dissemination in vivo.
@nl
type
label
Insulin-like growth factor rec ...... or cell dissemination in vivo.
@en
Insulin-like growth factor rec ...... or cell dissemination in vivo.
@nl
prefLabel
Insulin-like growth factor rec ...... or cell dissemination in vivo.
@en
Insulin-like growth factor rec ...... or cell dissemination in vivo.
@nl
P2093
P2860
P356
P1476
Insulin-like growth factor rec ...... or cell dissemination in vivo.
@en
P2093
D A Cheresh
M A Schwartz
P C Brooks
R L Klemke
P2860
P304
P356
10.1172/JCI119298
P407
P577
1997-03-01T00:00:00Z